This BPC-157 TB-500 research peptide set is supplied exclusively for in-vitro laboratory research by licensed researchers and qualified institutions. As a BPC-157 TB-500 research peptide product, each vial is independently tested, batch-matched, and documented before release.
For Research Use Only. This product is intended strictly for in-vitro laboratory research by licensed researchers and qualified professionals. It is not intended for human or animal consumption, therapeutic use, or self-administration. Not evaluated by the FDA. Handle per GLP guidelines.

BPC-157 TB-500 Research Peptide Overview
This research compound set contains two independently verified synthetic peptides — TB-500 (Thymosin Beta-4 synthetic analogue, 43 amino acids) and BPC-157 (Body Protection Compound, 15 amino acids). Both compounds are subjects of active preclinical research in cellular biology, tissue signaling, and extracellular matrix studies, and published findings are indexed on PubMed for researchers reviewing prior literature. Available exclusively for qualified researchers conducting in-vitro and laboratory studies.
Researchers selecting a BPC-157 TB-500 research peptide set for laboratory use can review full documentation, including CAS numbers and molecular weight data, prior to ordering. This BPC-157 TB-500 research peptide combination is frequently referenced in extracellular matrix and cellular signaling literature, making it a common subject for comparative in-vitro study designs.
- TB-500 — synthetic analogue of Thymosin Beta-4, an actin-binding peptide present in virtually all eukaryotic cells
- BPC-157 — pentadecapeptide derived from a sequence identified in human gastric juice protein
- Both compounds independently lyophilized and supplied with individual Certificates of Analysis
- Each vial batch-matched and verified prior to release
Researchers frequently request this BPC-157 TB-500 research peptide combination together because both compounds are commonly studied in related extracellular matrix and tissue-signaling pathways, allowing for direct comparative analysis within a single research design. Supplying both compounds from a single verified batch source reduces variability between experiments, since researchers can confirm both peptides underwent testing under equivalent laboratory conditions. Each compound in this set ships with its own individual documentation rather than a combined or generic certificate, so purity and identity can be verified independently for BPC-157 and TB-500 as distinct research materials.
- HPLC purity analysis confirming ≥99% peptide purity on both compounds prior to release
- Mass spectrometry verification of molecular weight and compound identity
- Endotoxin tested — sterile filtered, packaged under Class 100,000 cleanroom conditions
- Individual Certificate of Analysis for each compound matched to shipment by batch number
Full batch-specific documentation for this BPC-157 TB-500 research peptide set, along with every other compound we supply, is available on our Lab Reports & COA page, or as part of our full research compound catalog.
- Store all lyophilized compounds at -20°C, protected from light and moisture
- Reconstituted solutions: store at 4°C, use within 48–72 hours
- Avoid repeated freeze-thaw cycles to preserve compound integrity
- Handle under sterile conditions per GLP guidelines
Sold exclusively for in-vitro laboratory research. Not intended for human or animal administration, clinical trials, or diagnostic use. NexGen Research Labs assumes no liability for misuse outside of stated research application. Any researcher ordering this BPC-157 TB-500 research peptide set confirms they are a licensed professional purchasing solely for lawful laboratory research.
Third-Party Verified — Individual batch COA available for each compound upon request. Independent accredited laboratory testing on every lot.




Reviews
There are no reviews yet.